S.I. No. 852/2007 - European Communities (Infant formulae and Follow-on formulae) Regulations 2007

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 18th January, 2008.

I, MARY HARNEY, Minister for Health and Children, in exercise of the powers conferred on me by section 3 of the European Communities Act 1972 (No. 27 of 1972), and for the purpose of giving partial effect to Commission Directive 2006/141/EC ¹ of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC ² , and for the purpose of giving further effect to Council Directive 92/52/EEC ³ of 18 June 1992 on infant formulae and follow-on formulae intended for export to third countries, hereby make the following regulations:

PART 1 Preliminary

1.

• (2) These Regulations (other than Regulation 30(2)) come into operation on 1 January 2008.

• (3) Regulation 30(2) comes into operation on the 31 December 2009.

2.

“Act of 1998” means the Food Safety Authority of Ireland Act 1998 (No. 29 of 1998);

“approved examiner” means—

• (a) an Agricultural Inspector located at a Dairy Science Laboratory,

• (b) an Assistant Agricultural Inspector located at a Dairy Science Laboratory,

• (c) a Chief Medical Scientist located at an official laboratory,

• (d) a Consultant Microbiologist located at an official laboratory,

• (e) a Deputy Public Analyst located at a Public Analyst’s Laboratory,

• (f) an Executive Analytical Chemist located at a Public Analyst’s Laboratory,

• (g) a Public Analyst located at a Public Analyst’s Laboratory,

• (h) a person, or member of a class of persons, designated by the Minister pursuant to Regulation 24;

“authorised officer” means an authorised officer appointed under section 49 of the Act of 1998;

“Authority” means the Food Safety Authority of Ireland established under section 9 of the Act of 1998;

“claim”, “health claim”, “nutrition claim” and “reduction of disease risk claim” shall be defined in accordance with Article 2(2) of Regulation (EC) No 1924/2006 ⁴ ;

“Directive 2006/141/EC” means Commission Directive 2006/141/EC 1 of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC 2 ;

“Directive 92/52/EEC” means Council Directive 92/52/EEC 3 of 18 June 1992 on infant formulae and follow-on formulae intended for export to third countries;

“Directives” means Directive 2006/141/EC 1 and Directive 92/52/EEC 3 ;

“follow-on formulae” means foodstuffs intended for particular nutritional use by infants when appropriate complementary feeding is introduced and constituting the principal liquid element in a progressively diversified diet of such infants, and cognate words shall be construed accordingly;

“General Food Law Regulation” means Regulation (EC) No 178/2002 ⁵ of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority, and laying down procedures in matters of food safety;

“health care system” includes institutions or organisations engaged, directly or indirectly, in health care for mothers, infants and pregnant women, including nurseries or child-care institutions, and includes health workers in private practice;

“Health Service Executive” (HSE) means the Heath Service Executive established under section 6 of the Health Act 2004 (No. 42 of 2004);

“infant formulae” means foodstuffs intended for particular nutritional use by infants during the first months of life and satisfying by themselves the nutritional requirements of such infants, until the introduction of appropriate complementary feeding, and cognate words shall be construed accordingly;

“infants” means children under the age of 12 months;

“Minister” means the Minister for Health and Children;

“official agency” means an official agency carrying out functions under a service contract and acting on behalf of the Authority pursuant to section 48 of the Act of 1998;

“Official Controls Regulation” means Regulation (EC) No 882/2004 ⁶ of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules;

“official laboratory” means—

• (a) Dairy Science Laboratory, Backweston,

• (b) Public Analyst’s Laboratory, Cork,

• (c) Public Analyst’s Laboratory, Dublin,

• (d) Public Analyst’s Laboratory, Galway,

• (e) Public Health Laboratory, HSE, Dublin Mid-Leinster,

• (f) Public Health Laboratory, Sligo,

• (g) Public Health Laboratory, Waterford,

• (h) Public Health Microbiology Laboratory, Cork,

• (i) Public Health Microbiology Laboratory, Galway,

• (j) Public Health Microbiology Laboratory, Limerick,

• (j) a laboratory designated by the Minister pursuant to Regulation 24;

“pesticide residue” means the residue in infant formulae and follow-on formulae of a plant protection product, as defined in point 1 of Article 2 of Directive 91/414/EEC ⁷ , including its metabolites and products resulting from its degradation or reaction, and cognate words shall be construed accordingly;

“service contract” means a contract entered into between the Authority and an official agency pursuant to section 48 of the Act of 1998;

“young children” means children aged between one and three years.

• (2) A word or expression which is used in these Regulations and which is also used in the Directives or in the General Food Law Regulation has, unless the context otherwise requires, the same meaning in these Regulations as it has in the Directives or in the General Food Law Regulation.

• (3)
• (a) A reference in these Regulations to a Regulation is to a Regulation of these Regulations, unless it is indicated that reference to some other Regulations is intended.

• (b) A reference in these Regulations to a paragraph or subparagraph is to the paragraph or subparagraph of the provision in which the reference occurs, unless it is indicated that reference to some other provision is intended.

• (c) A reference in these Regulations to a Schedule is to a Schedule to these Regulations, unless it is indicated that reference to some other Regulations is intended.

• (d) A reference in these Regulations to an Article is to an Article of the Directives, unless it is indicated that reference to some other instrument is intended.

PART 2 Infant Formulae and Follow-On Formulae Intended to be Placed on the Market in a Member State

3.

• (2) A person shall not—

• (a) manufacture infant formulae or place infant formulae on the market unless the requirements of this Part applicable to infant formulae are complied with,

• (b) use the description ‘infant formula’ in the marketing of any product which is not infant formulae as defined in Regulation 2(1), or

• (c) represent any product which is not infant formulae as defined in Regulation 2(1) as being suitable for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life until the introduction of appropriate complementary feeding.

• (3) Infant formulae shall be placed on the market under the name ‘infant formula’, save where it is manufactured entirely from cows’ milk proteins, in which case it shall be sold under the name ‘infant milk’.

• (4) A person shall not—

• (a) manufacture follow-on formulae or place follow-on formulae on the market unless the requirements of this Part applicable to follow-on formulae are complied with, or

• (b) use the description ‘follow-on formula’ in the marketing of any product which is not follow-on formulae as defined in Regulation 2(1).

• (5) Follow-on formula shall be placed on the market under the name ‘follow-on formula’, save where it is manufactured entirely from cows’ milk proteins, in which case it shall be sold under the name ‘follow-on milk’.

• (6) The other names listed in Articles 11 and 12 of the Directive, or any of them, may also be included in addition to the names indicated in paragraphs (3) and (5).

• (7) A person shall not distribute, publish or issue any materials containing information on infant or young child feeding, unless the requirements of this Part are complied with.

4.

• (2) Suitability shall be demonstrated through a systematic review of the available data relating to the expected benefits and to safety considerations as well as, where necessary, appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

• (3) The prohibitions and limitations on the use of food ingredients in infant formulae set down in Schedule 1 shall be observed.

• (4) Subject to paragraphs (5) and (6), infant formulae shall comply with the compositional criteria specified in Schedule 1 taking into account the specifications in Schedule 5.

• (5) In the case of infant formulae manufactured from cows’ milk proteins specified in point 2.1 of Schedule 1 with a protein content between the minimum and 0.5g/100 kJ (2g/100 kcal), the suitability of the infant formula for the particular nutritional use by infants shall be demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

• (6) In the case of infant formulae manufactured from protein hydrolysates specified in point 2.2 of Schedule 1 with a protein content between the minimum and 0.56g/100 kJ (2.25g/100 kcal):

• (a) the suitability of the infant formula for the particular nutritional use by infants shall be demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies; and

• (b) the infant formula shall be in accordance with the appropriate specifications set out in Schedule 6.

• (7) In order to make infant formulae ready for use, nothing more shall be required than the addition of water.

• (8) Only the substances listed in Schedule 3 may be used in the manufacture of infant formulae in order to satisfy the requirements on mineral substances, vitamins, amino acids and other nitrogen compounds, and other substances having a particular nutritional purpose.

• (9) Purity criteria for substances, as provided for in Community legislation concerning the use of substances listed in Schedule 3, in the manufacture of foodstuffs for purposes other than those covered by Directive 2006/141/EC 1 , shall apply to infant formulae.

• (10) For those substances for which no purity criteria have been provided for in Community legislation, generally acceptable purity criteria recommended by international bodies shall apply to infant formulae until the adoption of such criteria at Community level.

• (11) Infant formulae shall not contain any substance in such quantity as to endanger the health of infants and young children.

• (12) Subject to paragraph (17), infant formulae shall not contain residues of individual pesticides at levels exceeding 0.01mg/kg of the product as proposed ready for consumption or as reconstituted according to the instructions of the manufacturer.

• (13) Analytical methods for determining the levels of pesticide residues shall be generally acceptable standardised methods.

• (14) Subject to paragraphs (15) and (16), those pesticides listed in Schedule 8 shall not be used in agricultural products intended for the production of infant formulae.

• (15) For the purposes of controls, pesticides listed in Table 1 of Schedule 8 are considered not to have been used if their residues do not exceed a level of 0.003mg/kg.

• (16) For the purposes of controls, pesticides listed in Table 2 of Schedule 8 are considered not to have been used if their residues do not exceed a level of 0.003mg/kg.

• (17) For the pesticides listed in Schedule 9, the maximum residue levels specified therein shall apply.

• (18) The levels referred to in paragraphs (15), (16) and (17) shall apply to the products as proposed ready for consumption or as reconstituted according to the instructions of the manufacturers.

5.

• (2) The prohibitions and limitations on the use of food ingredients in follow-on formulae set down in Schedule 2 shall be observed.

• (3) Follow-on formulae shall comply with the compositional criteria specified in Schedule 2 taking into account the specifications set out in Schedule 5.

• (4) In order to make follow-on formulae ready for use, nothing more shall be required than the addition of water.

• (5) Only the substances listed in Schedule 3 may be used in the manufacture of follow-on formulae in order to satisfy the requirements on mineral substances, vitamins, amino acids and other nitrogen compounds, and other substances having a particular nutritional purpose.

• (6) Purity criteria for substances, as provided for in Community legislation concerning the use of substances listed in Schedule 3, in the manufacture of foodstuffs for purposes other than those covered by Directive 2006/141/EC 1 , shall apply to follow-on formulae.

• (7) For those substances for which no purity criteria have been provided for in Community legislation, generally acceptable purity criteria recommended by international bodies shall apply to follow-on formulae until the adoption of such criteria at Community level.

• (8) Follow-on formulae shall not contain any substance in such quantity as to endanger the health of infants and young children.

• (9) Subject to paragraph (14), follow-on formulae shall not contain residues of individual pesticides at levels exceeding 0.01mg/kg of the product as proposed ready for consumption or as reconstituted according to the instructions of the manufacturer.

• (10) Analytical methods for determining the levels of pesticide residues shall be generally acceptable standardised methods.

• (11) Subject to paragraphs (12) and (13), those pesticides listed in Schedule 8 shall not be used in agricultural products intended for the production of follow-on formulae.

• (12) For the purposes of controls, pesticides listed in Table 1 of Schedule 8 are considered not to have been used if their residues do not exceed a level of 0.003mg/kg.

• (13) For the purposes of controls, pesticides listed in Table 2 of Schedule 8 are considered not to have been used if their residues do not exceed a level of 0.003mg/kg.

• (14) For the pesticides listed in Schedule 9, the maximum residue levels specified therein shall apply.

• (15) The levels referred to in paragraphs (12), (13) and (14) shall apply to the products as proposed ready for consumption or as reconstituted according to the instructions of the manufacturers.

6.

• (a) a statement to the effect that the product is suitable for particular nutritional use by infants from birth when they are not breast-fed,

• (b) the available energy value, expressed in kJ and kcal, per 100ml of the product ready for use,

• (c) the content of proteins, carbohydrates and lipids, expressed in numerical form, per 100ml of the product ready for use,

• (d) the average quantity of each mineral substance and of each vitamin mentioned in Schedule 1, expressed in numerical form, per 100ml of the product ready for use,

• (e) where applicable, the average quantity of choline, inositol and carnitine, expressed in numerical form, per 100ml of the product ready for use,

• (f) instructions for appropriate preparation, storage and disposal of the product, and

• (g) a warning against the health hazards of inappropriate preparation and storage.

• (2) The labelling of infant formulae may bear the average quantity of nutrients mentioned in Schedule 3 when such declaration is not covered by the provisions of subparagraphs (d) and (e) of paragraph (1), expressed in numerical form, per 100ml of the product ready for use.

• (3) The labelling of infant formulae shall be designed to provide the necessary information about the appropriate use of the products so as not to discourage breast-feeding.

• (4) In the labelling of infant formulae, the use of the terms ‘humanised’, ‘maternalised’, ‘adapted’ or similar terms shall be prohibited.

• (5) The labelling of infant formulae shall, in addition, bear the following mandatory particulars, preceded by the words ‘Important Notice’ or their equivalent:

• (a) a statement concerning the superiority of breast-feeding, and

• (b) a statement recommending that the product be used only on the advice of independent persons having qualifications in medicine, nutrition or pharmacy, or other professionals responsible for maternal and child care.

• (6) The labelling of infant formulae shall not include pictures of infants, nor shall it include other pictures or text which may idealise the use of the product. It may, however, include graphic representations for easy identification of the product and for illustrating methods of preparation.

• (7) The labelling of infant formulae may bear nutrition and health claims only in the cases listed in Schedule 4 and in accordance with the conditions set out therein.

• (8) Infant formulae shall be labelled in such a way as to enable consumers to make a clear distinction between infant formulae and follow-on formulae so as to avoid any risk of confusion between such products.

• (9) The requirements, prohibitions and restrictions referred to in paragraphs (3) to (8) shall also apply to:

• (a) the presentation of the products concerned, in particular their shape, appearance or packaging, the packaging materials used, the way in which they are arranged and the setting in which they are displayed, and

• (b) advertising.

• (10) A food business operator placing an infant formula product on the market in the State, shall notify the Authority of that placing on the market by forwarding to it a model of the label used for the product.

7.

• (a) a statement to the effect that the product is suitable only for particular nutritional use by infants over the age of 6 months, that it should form only part of a diversified diet, that it is not to be used as a substitute for breast milk during the first 6 months of life and that the decision to begin complementary feeding, including any exception to 6 months of age, should be made only on the advice of independent persons having qualifications in medicine, nutrition or pharmacy, or other professionals responsible for maternal and child care, based on the individual infant’s specific growth and development needs,

• (b) the available energy value, expressed in kJ and kcal, per 100ml of the product ready for use,

• (c) the content of proteins, carbohydrates and lipids, expressed in numerical form, per 100ml of the product ready for use,

• (d) the average quantity of each mineral substance and of each vitamin mentioned in Schedule 2, expressed in numerical form, per 100ml of the product ready for use,

• (e) where applicable, the average quantity of choline, inositol, and carnitine, expressed in numerical form, per 100ml of the product ready for use,

• (f) instructions for appropriate preparation, storage and disposal of the product, and

• (g) a warning against the health hazards of inappropriate preparation and storage.

• (2) The labelling of follow-on formulae may bear:

• (a) the average quantity of nutrients mentioned in Schedule 3 when such declaration is not covered by the provisions of subparagraphs (d) and (e) of paragraph (1), expressed in numerical form, per 100ml of the product ready for use, and

• (b) in addition to numerical information, information on vitamins and minerals included in Schedule 7, expressed as a percentage of the reference values given therein, per 100ml of the product ready for use.

• (3) The labelling of follow-on formulae shall be designed to provide the necessary information about the appropriate use of the products so as not to discourage breast-feeding.

• (4) In the labelling of follow-on formulae, the use of the terms ‘humanised’, ‘maternalised’, ‘adapted’ or similar terms shall be prohibited.

• (5) Follow-on formulae shall be labelled in such a way as to enable consumers to make a clear distinction between infant formulae and follow-on formulae so as to avoid any risk of confusion between such products.

• (6) The requirements, prohibitions and restrictions referred to in paragraphs (3) to (5) shall also apply to—

• (a) the presentation of the products concerned, in particular their shape, appearance or packaging, the packaging materials used, the way in which they are arranged and the setting in which they are displayed, and

• (b) advertising.

8.

• (2) The requirements, prohibitions and restrictions referred to in paragraphs (3) to (8) of Regulation 6 shall also apply to advertising, and advertisements for infant formulae shall be subject to the conditions laid down therein.

• (3) Advertisements for infant formulae shall contain only information of a scientific and factual nature.

• (4) Advertisements for infant formulae shall not imply or create a belief that bottle-feeding is equivalent or superior to breast-feeding.

• (5) There shall be no point-of-sale advertising, giving of samples or any other promotional device to induce sales of infant formula directly to the consumer at the retail level, such as special displays, discount coupons, premiums, special sales, loss-leaders and tie-in sales.

• (6) Manufacturers and distributors of infant formulae shall not provide, to the general public or to pregnant women, mothers or members of their families, free or low-priced products, samples or any other promotional gifts, either directly or indirectly via the health care system or health workers.

9.

• (2) Paragraph (1) shall apply to the planning, provision, design and dissemination of information and their control.

• (3) Informational and educational materials, whether written or audiovisual, dealing with the feeding of infants and intended to reach pregnant women and mothers of infants and young children, shall include clear information on all the following points:

• (a) the benefits and superiority of breast-feeding,

• (b) the importance of maternal nutrition and the preparation for and maintenance of breast-feeding,

• (c) the possible negative effect on breast-feeding of introducing partial bottle-feeding,

• (d) the difficulty of reversing the decision not to breast-feed, and

• (e) where needed, the proper use of infant formulae.

• (4) Where the materials referred to at paragraph (3) contain information about the use of infant formulae, they shall include information on the social and financial implications of its use, the health hazards of inappropriate foods or feeding methods, and, in particular, the health hazards of improper use of infant formulae.

• (5) The materials referred to at paragraph (3) shall not use any pictures which may idealise the use of infant formulae.

• (6) Donations of informational or educational equipment or materials by manufacturers or distributors shall be made only on request and with the written approval of the Authority or within guidelines issued by the Authority for that purpose.

• (7) The equipment and materials referred to at paragraph (6) may bear the donating company’s name or logo, but shall not refer to a proprietary brand of infant formulae and shall be distributed only through the health care system.

• (8) Donations and low-price sales of supplies of infant formulae to institutions or organisations, whether for use in the institutions or for distribution outside them, shall only be used by or distributed for infants who have to be fed on infant formulae and only for as long as required by such infants.

10.

PART 3 Infant Formulae and Follow-On Formulae Intended for Export to Third Countries

11.

12.

• (a) export infant formulae unless the requirements of this Part applicable to infant formulae are complied with,

• (b) use the description ‘infant formula’ in the marketing of any product intended for export, which is not infant formulae as defined in Regulation 2(1), or

• (c) represent any product intended for export, which is not infant formulae as defined in Regulation 2(1), as being suitable for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life.

• (2) Unless otherwise requested or stipulated by provisions established by the importing country, and subject to Article 12 of the General Food Law Regulation, a person shall not export infant formulae unless:

• (a) either the requirements set down in Regulation 4 of these Regulations or the relevant applicable world standards established by Codex Alimentarius are complied with,

• (b) the requirements set down in paragraphs (1) to (7) of Regulation 6 of these Regulations are complied with, and

• (c) the provisions of Council Directive 89/396/EEC ⁹ of 14 June 1989 on indications or marks identifying the lot to which a foodstuff belongs, are complied with.

• (3) The stipulations, prohibitions and restrictions laid down in paragraphs (1) to (7) of Regulation 6 of these Regulations shall also apply to the presentation of infant formulae intended for export, and in particular their form, aspect or packaging and the packaging materials used.

13.

• (a) export follow-on formulae unless the requirements of this Part applicable to follow-on formulae are complied with, or

• (b) use the description ‘follow-on formula’ in the marketing of any product intended for export which is not follow-on formulae as defined in Regulation 2(1).

• (2) Unless otherwise requested or stipulated by provisions established by the importing country, and subject to Article 12 of the General Food Law Regulation, a person shall not export follow-on formulae, unless—

• (a) either the requirements set down in Regulation 5 of these Regulations or the relevant applicable world standards established by Codex Alimentarius are complied with,

• (b) the requirements set down in paragraphs (1) to (4) of Regulation 7 of these Regulations are complied with, and

• (c) the provisions of Council Directive 89/396/EEC 9 of 14 June 1989 on indications or marks identifying the lot to which a foodstuff belongs, are complied with.

• (3) The stipulations, prohibitions and restrictions laid down in paragraphs (1) to (4) of Regulation 7 shall also apply to the presentation of follow-on formulae intended for export, and in particular their form, aspect or packaging and the packaging materials used.

14.

• (2) Infant formulae and follow-on formulae intended for export shall be labelled in such a way as to avoid any risk of confusion between them.

PART 4 Enforcement

15.

• (2) These Regulations shall be deemed to be food legislation for the purposes of the Act of 1998.

• (3) These Regulations shall be enforced by the Authority or by an official agency acting pursuant to a service contract with the Authority, or by both, and, without prejudice to paragraph (1), the enforcement provisions contained in the Act of 1998 shall apply for the purposes of ensuring compliance with the requirements of these Regulations.

16.

• (2) An authorised officer may, for the purpose of taking a sample of infant formulae or follow-on formulae or other relevant substance, open any receptacle.

• (3) Where an authorised officer purchases or takes without payment a sample of infant formulae or follow-on formulae or other relevant substance with the intention of having it analysed, he or she shall after purchasing or taking the sample forthwith notify the food business operator, or the person in apparent charge or control of the infant formulae or follow-on formulae or other substance of his or her intention of having the sample analysed.

• (4) Where an authorised officer purchases or takes without payment, with the intention of having it analysed, a sample of infant formulae or follow-on formulae or other relevant substance which is suspected by him or her to fail to comply with the provisions of these Regulations, he or she may, by notice in writing to the food business operator, or the person in apparent charge or control of such foods or other substances, prohibit their removal except to any place which may be specified in the notice, during such period as may be specified in the notice, but not exceeding 15 days from the date of the taking of the sample.

17.

• (a) mark, seal and fasten each part in such a manner as its nature will permit, and in such a way that the integrity of the sample is not compromised;

• (b) forward one part to the approved examiner in an official laboratory for analysis;

• (c) give or send one part to the food business operator, and

• (d) retain the third part.

• (2) Where an authorised officer takes a sample consisting of infant formulae or follow-on formulae or other relevant substance contained in unopened containers and its division into parts:

• (a) is not reasonably practicable, or

• (b) might affect the composition or impede the proper analysis of the sample,

the provisions of paragraph (1) as regards the division of samples into parts shall be deemed to be complied with if the authorised officer divides the containers into three lots and deals with each lot as if it were a sample as specified under paragraph (1).

• (3) In proceedings for an offence under these Regulations, the result of any test, examination or analysis of, or report on a sample of infant formulae or follow-on formulae or other relevant substance taken pursuant to these Regulations, shall not be adduced unless before the proceedings were instituted the sample was divided as specified in paragraphs (1) and (2) of this Regulation. The part, package or container retained by the authorised officer shall be produced at the hearing.

18.

• (2) An official certificate given in accordance with paragraph (1) shall be prima facie evidence of the matters contained therein until the contrary is proved.

19.

20.

• (a) labels used on infant formulae, follow-on formulae, or other products being placed on the market as such, or

• (b) informational materials.

21.

• (a) products which are not infant formulae or follow-on formulae, as defined in Regulation 2(1), but which are being placed on the market as such, and

• (b) any other products which the authorised officer suspects are being treated, manufactured or placed on the market in contravention of these Regulations.

22.

• (2) An authorised officer may, with the consent in writing of the food business operator, or the person in apparent charge or control of such infant formulae or follow-on formulae or other products or in accordance with an order of a judge of the District Court under paragraph (4) of this Regulation, destroy or otherwise dispose of same so as to prevent them being used for human consumption.

• (3) An authorised officer who has seized, removed, detained or directed the withdrawal from the market of infant formulae or follow-on formulae or other products in pursuance of the provisions of this Regulation may, on giving notice in writing to the food business operator of his or her intention to do so, apply to a judge of the District Court for an order directing that such products be destroyed or otherwise disposed of.

• (4) A judge of the District Court, to whom an application is made for an order under paragraph (3), may, if satisfied that such foods or products fail to comply with these Regulations, order that they be destroyed or otherwise disposed of, after such period, not exceeding 14 days, as may be specified in such order, and an authorised officer shall destroy or dispose of them accordingly.

23.

24.

• (a) a laboratory as a laboratory at which samples taken under these Regulations may be analysed, and testing and verification may be carried out, and

• (b) a person as being a person who, or a class of persons the members of which, may, at a designated laboratory, engage in analysis, testing and verification for the purposes of these Regulations.

25.

• (2) Paragraph (1) shall not apply to an authorised officer or an approved examiner acting in the course of his or her duties pursuant to these Regulations.

• (3) A person is guilty of an offence if he or she:

• (a) obstructs or interferes with an authorised officer in the exercise of the officer’s powers under these Regulations,

• (b) fails or refuses to state his or her name or address in compliance with a request under these Regulations,

• (c) fails to comply with a request or notice from an authorised officer under these Regulations,

• (d) makes a statement to an authorised officer which the person knows is false or misleading, or

• (e) gives in purported compliance with a request under these Regulations a name, address or corroborative evidence which is false or misleading,

26.

27.

• (2) A person is guilty of an offence if he or she alters with intent to defraud or deceive, or who utters knowing it to be so altered, a certificate of analysis or other document issued, granted or given under these Regulations, or required for the purposes of these Regulations (hereafter referred to as “an altered document”).

• (3) A person is guilty of an offence if he or she without lawful authority, has in his or her possession a forged document or an altered document, knowing it to be a forged or altered document as the case may be.

• (4) A person is guilty of an offence if he or she with the intent to defraud or deceive:

• (a) tampers with any substance or thing with the result that a sample taken pursuant to these Regulations does not correctly represent the substance sampled, or

• (b) tampers or interferes with any sample taken under these Regulations.

• (5) A person is guilty of an offence if he or she falsely represents himself or herself to be an authorised officer.

28.

• (2) A person who is guilty of an offence under these Regulations is liable:

• (a) on summary conviction to a fine not exceeding €5,000 or at the discretion of the Court to imprisonment for a term not exceeding 3 months, or both, or,

• (b) on conviction on indictment, to a fine not exceeding €500,000, or imprisonment for a term not exceeding 3 years, or both.

29.

• (a) the Authority, or

• (b) an official agency

or both.

PART 5 Revocations and Transitional Arrangements

30.

• (2) The following are revoked:

• (a) the European Communities (Infant Formulae and Follow-on Formulae) Regulations 2004 ( S.I. No. 242 of 2004 ), and

• (b) the European Communities (Infant Formulae and Follow-on Formulae) (Amendment) Regulations 2007 ( S.I. No. 242 of 2007 ).

• (3) No person commits an offence under regulation 25(1) consisting of a contravention of or failure to comply with:

• (a) Regulation 3 where there is no contravention of or failure to comply with Regulation 3 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004,

• (b) Regulation 4 where there is no contravention of or failure to comply with Regulation 4 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004,

• (c) Regulation 5 where there is no contravention of or failure to comply with Regulation 5 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004,

• (d) Regulation 6 where there is no contravention of or failure to comply with Regulation 6 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004,

• (e) Regulation 7 where there is no contravention of or failure to comply with Regulation 7 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004,

• (f) Regulation 12 where there is no contravention of or failure to comply with Regulation 11 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004,

• (g) Regulation 13 where there is no contravention of or failure to comply with Regulation 12 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004.

• (4) Regulation 24 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2004 ( S.I. No. 242 of 2004 ) is amended by inserting after paragraph (2) the following paragraph:

• “(3) No person commits an offence under paragraph (1) consisting of a contravention of or failure to comply with:

  • (a) Regulation 3, where there is no contravention of or failure to comply with Regulation 3 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2007,

  • (b) Regulation 4 where there is no contravention of or failure to comply with Regulation 4 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2007,

  • (c) Regulation 5 where there is no contravention of or failure to comply with Regulation 5 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2007,

  • (d) Regulation 6 where there is no contravention of or failure to comply with Regulation 6 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2007,

  • (e) Regulation 7 where there is no contravention of or failure to comply with Regulation 7 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2007,

  • (f) Regulation 11 where there is no contravention of or failure to comply with Regulation 12 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2007,

  • (g) Regulation 12 where there is no contravention of or failure to comply with Regulation 13 of the European Communities (Infant Formulae and Follow-On Formulae) Regulations 2007.”.

SCHEDULE 1 ESSENTIAL COMPOSITION OF INFANT FORMULAE WHEN RECONSTITUTED AS INSTRUCTED BY THE MANUFACTURER

The values set out in this Schedule refer to the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer.

1. Energy

Minimum 250 kJ/100ml (60 kcal/100ml)

Maximum 295 kJ/100ml (70 kcal/100ml)

2. Proteins

(Protein content = nitrogen content x 6.25)

2.1 Infant Formulae manufactured from cows’ milk proteins

Minimum ^(1) 0.45g/100 kJ (1.8g/100 kcal)

Maximum 0.7g/100 kJ (3g/100 kcal)

(¹) Infant formulae manufactured from cows’ milk protein with a protein content between the minimum and 0.5g/100 kJ (2g/100 kcal) shall be in accordance with Regulation 4(5).

For an equal energy value, the infant formula must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5). Nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together if the methionine:cystine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cystine may be greater than 2 but shall not be greater than 3 provided that the suitability of the product for the particular nutritional use by infants is demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

2.2 Infant formulae manufactured from protein hydrolysates

Minimum ^(1) 0.45g/100 kJ (1.8g/100 kcal)

Maximum 0.7g/100 kJ (3g/100 kcal)

(¹) Infant formulae manufactured from protein hydrolysates with a protein content between the minimum and 0.56g/100 kJ(2.25g/100 kcal) shall be in accordance with Regulation 4(6).

For an equal energy value, the infant formula must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5). Nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together if the methionine:cystine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio ofmethionine:cystine may be greater than 2 but shall not be greater than 3 provided that the suitability of the product for the particular nutritional use by infants is demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

The L-carnitine content shall be at least equal to 0.3mg/100 kJ (1.2mg/100 kcal).

2.3 Infant formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk proteins

Minimum 0.56g/100 kJ (2.25g/100 kcal)

Maximum 0.7g/100 kJ (3g/100 kcal)

Only protein isolates from soya shall be used in manufacturing these infant formulae.

For an equal energy value the infant formula must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5). Nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together if the methionine:cystine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine: cystine may be greater than 2 but shall not be greater than 3 provided that the suitability of the product for the particular nutritional use by infants is demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

The L-carnitine content shall be at least equal to 0.3mg/100 kJ (1.2mg/100 kcal).

2.4 In all cases, amino acids may be added to infant formulae solely for the purpose of improving the nutritional value of the proteins, and only in the proportions necessary for that purpose.

3. Taurine

If added to infant formulae, the amount of taurine shall not be greater than 2.9mg/100 kJ (12mg/100 kcal).

4. Choline

Minimum 1.7mg/100 kJ (7mg/100 kcal)

Maximum 12mg/100 kJ (50mg/100 kcal)

5. Lipids

Minimum 1.05g/100 kJ (4.4g/100 kcal)

Maximum 1.4g/100 kJ (6.0g/100 kcal)

5.1 The use of the following substances shall be prohibited:

— sesame seed oil,

— cotton seed oil,

5.2 Lauric acid and myristic acid

Minimum No minimum specified

Maximum separately or as a whole:20% of the total fat content.

5.3 The trans fatty acid content shall not exceed 3% of the total fat content.

5.4 The erucic acid content shall not exceed 1% of the total fat content.

5.5 Linoleic acid (in the form of glycerides = linoleates)

Minimum 70mg/100 kJ (300mg/100 kcal)

Maximum 285mg/100 kJ (1200mg/100 kcal)

5.6 The alpha-linolenic acid content shall not be less than 12mg/100 kJ (50mg/100 kcal).

The linoleic:alpha-linolenic acid ratio shall not be less than 5 nor greater than 15.

5.7 Long-chain (20 and 22 carbon atoms) polyunsaturated fatty acids (LCP) may be added. In that case their content shall not exceed:

—1% of the total fat content for n-3 LCP, and

—2% of the total fat content for n-6 LCP (1% of the total fat content for arachidonic acid (20:4 n-6))

The eicosapentaenoic acid (20:5 n-3) content shall not exceed that of docosahexaenoic (22:6 n-3) acid content.

The docosahexaenoic acid (22:6 n-3) content shall not exceed that of n-6 LCP.

6. Phospholipids

The amount of phospholipids in infant formulae shall not be greater than 2g/l.

7. Inositol

Minimum 1mg/100 kJ (4mg/100 kcal)

Maximum 10mg/100 kJ (40mg/100 kcal)

8. Carbohydrates

Minimum 2.2g/100 kJ (9g/100 kcal)

Maximum 3.4g/100 kJ (14g/100 kcal)

8.1 Only the following carbohydrates may be used:

—lactose,

—maltose,

—sucrose,

—glucose,

—malto-dextrins,

—glucose syrup or dried glucose syrup,

—pre-cooked starch — naturally free of gluten,

—gelatinised starch — naturally free of gluten.

8.2 Lactose

Minimum 1.1g/100 kJ (4.5g/100 kcal)

Maximum No maximum specified

This provision shall not apply to infant formulae in which soya protein isolates represent more than 50% of the total protein content.

8.3 Sucrose

Sucrose may only be added to infant formulae manufactured from protein hydrolysates. If added, the sucrose content shall not exceed 20% of the total carbohydrate content.

8.4 Glucose

Glucose may only be added to infant formulae manufactured from protein hydrolysates. If added, the glucose content shall not exceed 0.5g/100 kJ (2g/100 kcal).

8.5 Pre-cooked starch and/or gelatinised starch

Minimum No minimum specified

Maximum 2g/100ml, and 30% of the total carbohydrate content

9. Fructo-Oligosaccharides and Galacto-Oligosaccharides

Fructo-oligosaccharides and galacto-oligosaccharides may be added to infant formulae. In that case their content shall not exceed: 0.8g/100 ml in a combination of 90% oligogalactosyl-lactose and 10% high molecular weight oligofructosyl-saccharose.

Other combinations and maximum levels of fructo-oligosaccharides and galacto-oligosaccharides may be used in accordance with Regulations 4(1) and 4(2).

10. Mineral Substances

10.1 Infant Formulae manufactured from cows’ milk proteins or protein hydrolysates

	Per 100 kJ	Per 100 kJ	Per 100 kcal	Per 100 kcal
	Minimum	Maximum	Minimum	Maximum
Sodium (mg)	5	14	20	60
Potassium(mg)	15	38	60	160
Chloride (mg)	12	38	50	160
Calcium (mg)	12	33	50	140
Phosphorus (mg)	6	22	25	90
Magnesium (mg)	1.2	3.6	5	15
Iron (mg)	0.07	0.3	0.3	1.3
Zinc (mg)	0.12	0.36	0.5	1.5
Copper (μg)	8.4	25	35	100
Iodine (μg)	2.5	12	10	50
Selenium (μg)	0.25	2.2	1	9
Manganese (μg)	0.25	25	1	100
Fluoride (μg)	-	25	-	100

The calcium:phosphorus ratio shall not be less than 1 nor greater than 2.

10.2 Infant formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk proteins

All requirements of point 10.1 shall apply, except for those concerning iron and phosphorus, which shall be as follows:

	Per 100 kJ	Per 100 kJ	Per 100 kcal	Per 100 kcal
	Minimum	Maximum	Minimum	Maximum
Iron (mg)	0.12	0.5	0.45	2
Phosphorus (mg)	7.5	25	30	100

11. Vitamins

	Per 100 kJ	Per 100 kJ	Per 100 kcal	Per 100 kcal
	Minimum	Maximum	Minimum	Maximum
Vitamin A (μg —RE) (1)	14	43	60	180
Vitamin D (μg) (2)	0.25	0.65	1	2.5
Thiamin (μg)	14	72	60	300
Riboflavin (μg)	19	95	80	400
Niacin (μg) (3)	72	375	300	1500
Pantothenic acid (μg)	95	475	400	2000
Vitamin B6 (μg)	9	42	35	175
Biotin (μg)	0.4	1.8	1.5	7.5
Folic Acid (μg)	2.5	12	10	50
Vitamin B 12 (μg)	0.025	0.12	0.1	0.5
Vitamin C (mg)	2.5	7.5	10	30
Vitamin K (μg)	1	6	4	25
Vitamin E (mg α—TE) (4)	0.5/g poly-unsaturated fatty acids expressed as linoleic acid as corrected for the double bonds ( 5 ) but in no case less than 0.1mg per 100 available kJ	1.2	0.5/g poly-unsaturated fatty acids expressed as linoleic acid as corrected for the double bonds ( 5 ) but in no case less than 0,5mg per 100 available kcal	5
(1>) RE = all trans retinol equivalent.	(1>) RE = all trans retinol equivalent.	(1>) RE = all trans retinol equivalent.	(1>) RE = all trans retinol equivalent.	(1>) RE = all trans retinol equivalent.
(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.
(3) Preformed niacin.	(3) Preformed niacin.	(3) Preformed niacin.	(3) Preformed niacin.	(3) Preformed niacin.
(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.
(5) 0,5mg α-TE/1g linoleic acid (18:2 n-6); 0,75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg -TE/1g arachidonic acid (20:4 n-6); 1,25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0,5mg α-TE/1g linoleic acid (18:2 n-6); 0,75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg -TE/1g arachidonic acid (20:4 n-6); 1,25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0,5mg α-TE/1g linoleic acid (18:2 n-6); 0,75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg -TE/1g arachidonic acid (20:4 n-6); 1,25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0,5mg α-TE/1g linoleic acid (18:2 n-6); 0,75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg -TE/1g arachidonic acid (20:4 n-6); 1,25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0,5mg α-TE/1g linoleic acid (18:2 n-6); 0,75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg -TE/1g arachidonic acid (20:4 n-6); 1,25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).

12. Nucleotides

The following nucleotides may be added:

	Maximum(1)	Maximum(1)
	(mg/100 kJ)	(mg/100 kcal)
cytidine 5’-monophosphate uridine 5’-monophosphate adenosine 5’-monophosphate guanosine 5’-monophosphate inosine 5’-monophosphate	0.60 0.42 0.36 0.12 0.24	2.50 1.75 1.50 0.50 1.00
(1) The total concentration of nucleotides shall not exceed 1.2mg/100 kJ (5mg/100 kcal).	(1) The total concentration of nucleotides shall not exceed 1.2mg/100 kJ (5mg/100 kcal).	(1) The total concentration of nucleotides shall not exceed 1.2mg/100 kJ (5mg/100 kcal).

SCHEDULE 2 ESSENTIAL COMPOSITION OF FOLLOW-ON FORMULAE WHEN RECONSTITUTED AS INSTRUCTED BY THE MANUFACTURER

The values set out in this Schedule refer to the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer.

1. Energy

Minimum 250 kJ /100ml (60 kcal/100ml)

Maximum 295 kJ /100ml (70 kcal/100ml)

2. Proteins

(Protein content = nitrogen content x 6.25)

2.1 Follow-on formulae manufactured from cows’ milk proteins

Minimum 0.45g/100 kJ (1.8g/100 kcal)

Maximum 0.8g/100 kJ (3.5g/100 kcal)

For an equal energy value, the follow-on formula must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5).

Nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together if the methionine:cystine ratio is not greater than 3, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2.

2.2 Follow-on formulae manufactured from protein hydrolysates

Minimum 0.56g/100 kJ (2.25g/100 kcal)

Maximum 0.8g/100 kJ (3.5g/100 kcal)

For an equal energy value, the follow-on formula must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5).

Nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together if the methionine:cystine ratio is not greater than 3, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2.

2.3 Follow-on formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk proteins

Minimum 0.56g/100 kJ (2.25g/100 kcal)

Maximum 0.8g/100 kJ (3.5g/100 kcal)

Only protein isolates from soya shall be used in manufacturing these formulae.

For an equal energy value the follow-on formula must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein (breast milk, as defined in Schedule 5).

Nevertheless, for calculation purposes, the concentration of methionine and cystine may be added together if the methionine:cystine ratio is not greater than 3, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2.

2.4 In all cases, amino acids may be added to follow-on formulae solely for the purpose of improving the nutritional value of the proteins, and only in the proportions necessary for that purpose.

3. Taurine

If added to follow-on formulae, the amount of taurine shall not be greater than 2.9mg/100 kJ (12mg/100 kcal).

4. Lipids

Minimum 0.96g/100 kJ (4.0g/100 kcal)

Maximum 1.4g/100 kJ (6.0g/100 kcal)

4.1 The use of the following substances shall be prohibited:

—sesame seed oil,

—cotton seed oil.

4.2 Lauric acid and myristic acid

Minimum No minimum specified

Maximum separately or as a whole:20% of the total fat content.

4.3 The trans fatty acid content shall not exceed 3% of the total fat content.

4.4 The erucic acid content shall not exceed 1% of the total fat content.

4.5 Linoleic acid (in the form of glycerides = linoleates)

Minimum 70mg/100 kJ (300mg/100 kcal)

Maximum 285mg/100 kJ (1200mg/100 kcal)

4.6 The alpha-linolenic acid content shall not be less than 12mg/100 kJ (50mg/100 kcal).

The linoleic:alpha-linolenic acid ratio shall not be less than 5 nor greater than 15.

4.7 Long-chain (20 and 22 carbon atoms) polyunsaturated fatty acids (LCP) may be added. In that case their content shall not exceed:

—1% of the total fat content for n-3 LCP, and

—2% of the total fat content for n-6 LCP (1% of the total fat content for arachidonic acid (20:4 n-6))

The eicosapentaenoic acid (20:5 n-3) content shall not exceed that of docosahexaenoic (22:6 n-3) acid content.

The docosahexaenoic (22:6 n-3) acid content shall not exceed that of n-6 LCP.

5. Phospholipids

The amount of phospholipids in follow-on formulae shall not be greater than 2g/l.

6. Carbohydrates

Minimum 2.2g/100 kJ (9g/100 kcal)

Maximum 3.4g/100 kJ (14g/100 kcal)

6.1 The use of ingredients containing gluten shall be prohibited.

6.2 Lactose

Minimum 1.1g/100 kJ (4.5g/100 kcal)

Maximum No maximum specified

This provision shall not apply to follow-on formulae in which soya protein isolates represent more than 50% of the total protein content.

6.3 Sucrose, fructose, honey

Minimum No minimum specified

Maximum separately or as a whole:20% of the total carbohydrate content.

Honey shall be treated to destroy spores of Clostridium botulinum

6.4 Glucose

Glucose may only be added to follow-on formulae manufactured from protein hydrolysates. If added, the glucose content shall not exceed 0.5g/100 kJ (2g/100 kcal).

7. Fructo-Oligosaccharides and Galacto-Oligosaccharides

Fructo-oligosaccharides and galacto-oligosaccharides may be added to follow-on formulae. In that case their content shall not exceed: 0.8g/100 ml in a combination of 90% oligogalactosyl-lactose and 10% high molecular weight oligofructosyl-saccharose. Other combinations and maximum levels of fructo-oligosaccharides and galacto-oligosaccharides may be used in accordance with Regulation 5(1).

8. Mineral substances

8.1 Follow-on formulae manufactured from cows’ milk proteins or protein hydrolysates

	Per 100 kJ	Per 100 kJ	Per 100 kcal	Per 100 kcal
	Minimum	Maximum	Minimum	Maximum
Sodium (mg)	5	14	20	60
Potassium (mg)	15	38	60	160
Chloride (mg)	12	38	50	160
Calcium (mg)	12	33	50	140
Phosphorus (mg)	6	22	25	90
Magnesium (mg)	1.2	3.6	5	15
Iron (mg)	0.14	0.5	0.6	2
Zinc (mg)	0.12	0.36	0.5	1.5
Copper (μg)	8.4	25	35	100
Iodine (μg)	2.5	12	10	50
Selenium (μg)	0.25	2.2	1	9
Manganese (μg)	0.25	25	1	100
Fluoride (μg)	-	25	-	100

The calcium:phosphorus ratio in follow-on formulae shall not be less than 1.0 nor greater than 2.0.

8.2. Follow-on formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk proteins

All requirements of point 8.1 shall apply, except for those concerning iron, and phosphorus, which shall be as follows:

	Per 100 kJ	Per 100 kJ	Per 100 kcal	Per 100 kcal
	Minimum	Maximum	Minimum	Maximum
Iron (mg)	0.22	0.65	0.9	2.5
Phosphorus (mg)	7.5	25	30	100

9. Vitamins

	Per 100 kJ	Per 100 kJ	Per 100 kcal	Per 100 kcal
	Minimum	Maximum	Minimum	Maximum
Vitamin A (μg —RE) (1)	14	43	60	180
Vitamin D (μg) (2)	0.25	0.75	1	3
Thiamin (μg)	14	72	60	300
Riboflavin (μg)	19	95	80	400
Niacin (μg) (3)	72	375	300	1500
Pantothenic acid (μg)	95	475	400	2000
Vitamin B6 (μg)	9	42	35	175
Biotin (μg)	0.4	1.8	1.5	7.5
Folic Acid (μg)	2.5	12	10	50
Vitamin B12 (μg)	0.025	0.12	0.1	0.5
Vitamin C (mg)	2.5	7.5	10	30
Vitamin K (μg)	1	6	4	25
Vitamin E (mg α—TE) (4)	0.5/g poly-unsaturated fatty acids expressed as linoleic acid as corrected for the double bonds ( 5 ) but in no case less than 0.1mg per 100 available kJ	1.2	0.5/g poly-unsaturated fatty acids expressed as linoleic acid as corrected for the double bonds ( 5 ) but in no case less than 0.5mg per 100 available kcal	5
(1) RE = all trans retinol equivalent.	(1) RE = all trans retinol equivalent.	(1) RE = all trans retinol equivalent.	(1) RE = all trans retinol equivalent.	(1) RE = all trans retinol equivalent.
(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.	(2) In the form of cholecalciferol, of which 10μg = 400 i.u. of vitamin D.
(3) Preformed niacin.	(3) Preformed niacin.	(3) Preformed niacin.	(3) Preformed niacin.	(3) Preformed niacin.
(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.	(4) α - TE = d- α - tocopherol equivalent.
(5) 0.5mg α-TE/1g linoleic acid (18:2 n-6); 0.75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg α-TE/1g arachidonic acid (20:4 n-6); 1.25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0.5mg α-TE/1g linoleic acid (18:2 n-6); 0.75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg α-TE/1g arachidonic acid (20:4 n-6); 1.25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0.5mg α-TE/1g linoleic acid (18:2 n-6); 0.75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg α-TE/1g arachidonic acid (20:4 n-6); 1.25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0.5mg α-TE/1g linoleic acid (18:2 n-6); 0.75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg α-TE/1g arachidonic acid (20:4 n-6); 1.25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).	(5) 0.5mg α-TE/1g linoleic acid (18:2 n-6); 0.75mg α-TE/1g -linolenic acid (18:3 n-3); 1.0mg α-TE/1g arachidonic acid (20:4 n-6); 1.25mg α-TE/1g eicosapentaenoic acid (20:5 n-3); 1.5mg α-TE/1g docosahexaenoic acid (22:6 n-3).

10. Nucleotides

The following nucleotides may be added:

	Maximum(1)	Maximum(1)
	(mg/100 kJ)	(mg/100 kcal)
cytidine 5’-monophosphate uridine 5’-monophosphate adenosine 5’-monophosphateguanosine 5’-monophosphate inosine 5’-monophosphate	0.600.420.360.120.24	2.501.751.500.501.00
(1) The total concentration of nucleotides shall not exceed 1.2mg/100 kJ (5mg/100 kcal).	(1) The total concentration of nucleotides shall not exceed 1.2mg/100 kJ (5mg/100 kcal).	(1) The total concentration of nucleotides shall not exceed 1.2mg/100 kJ (5mg/100 kcal).

SCHEDULE 3 NUTRITIONAL SUBSTANCES

1. Vitamins

Vitamin	Vitamin Formulation
Vitamin A	Retinyl acetate Retinyl palmitate Retinol
Vitamin D	Vitamin D2 (ergocalciferol) Vitamin D3 (cholecalciferol)
Vitamin B1	Thiamin hydrochloride Thiamin mononitrate
Vitamin B2	Riboflavin Riboflavin-5’-phosphate, sodium
Niacin	Nicotinamide Nicotinic acid
Vitamin B6	Pyridoxine hydrochloride Pyridoxine-5’-phosphate
Folate	Folic acid
Pantothenic acid	D-pantothenate, calcium D-pantothenate, sodium Dexpanthenol
Vitamin B12	Cyanocobalamin Hydroxocobalamin
Biotin	D-biotin
Vitamin C	L-ascorbic acid Sodium L-ascorbate Calcium L-ascorbate 6-palmityl-L-ascorbic acid (ascorbyl palmitate) Potassium ascorbate
Vitamin E	D-alpha tocopherol DL-alpha tocopherol D-alpha tocopherol acetate DL-alpha tocopherol acetate
Vitamin K	Phylloquinone (Phytomenadione)

2. Mineral substances